Migraine Without Aura clinical trials

Explore recruiting migraine without aura clinical trials.

Recruiting migraine without aura studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Migraine Without Aura trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The headache-inducing effects of cilostazol in men and women with migraine without aura

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

The headache-inducing effects of sildenafil in men and women with episodic migraine without aura.

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

The headache- and migraine-inducing effects of apremilast in women with migraine without aura

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

The headache- and migraine-inducing effects of pitolisant in women with migraine without aura

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults

Belgium

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A Phase 3, Multicenter, 12-Week, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atogepant for the Preventive Treatment of Episodic Migraine in Pediatric Subjects 6 to 17 years of age

Sweden, Hungary, Belgium, Denmark, Italy, France +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Migraine Without Aura trials by city

Migraine Without Aura in Toronto Migraine Without Aura in Vancouver Migraine Without Aura in Montreal Migraine Without Aura in Calgary Migraine Without Aura in Edmonton Migraine Without Aura in Ottawa Migraine Without Aura in Winnipeg Migraine Without Aura in Quebec City Migraine Without Aura in Hamilton Migraine Without Aura in Kitchener Migraine Without Aura in London Migraine Without Aura in Halifax Migraine Without Aura in New York Migraine Without Aura in Los Angeles Migraine Without Aura in Chicago Migraine Without Aura in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease